Search Results
On the Frontlines in Latin America with Save the Children
A closer look at how one of Baxter International Foundation’s partners, Save the Children, is taking a holistic approach to supporting communities throughout COVID-19’s epicenter
Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of All Sigma Spectrum Infusion Pumps (V6, V8, and IQ)
Baxter International Inc. announced today it has issued an Urgent Device Correction to reinforce important safety information regarding cleaning practices of all Spectrum infusion pumps distributed in the United States, Canada, and the Caribbean, as deviations from the specified cleaning methods may impair infusion pump functionality and performance.
Baxter Supports New Study Showing Blood Purification with Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients
Baxter International Inc. (NYSE:BAX), a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from the OxirisNet Registry evaluating severely ill patients with COVID-19 in Italy treated with extracorporeal (outside the body) blood purification (EBP) using the company’s Oxiris filter set.
Baxter to Present at 29th Annual Credit Suisse Virtual Healthcare Conferencce
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference via webcast on Monday, November 9, 2020. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 11:45 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through November 9, 2021.
Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition
A global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) approval of new formulations of Clinimix (amino acids in dextrose) Injections and Clinimix E (amino acids with electrolytes in dextrose and calcium) Injections.
Baxter Announces Support for Finalization of Core Component of the Advancing American Kidney Health Initiative
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today issued this statement:
Baxter Announces Exclusive Distribution Agreement with bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test. The NEPHROCLEARTM CCL14 test is currently in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI).
Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.